SAN DIEGO, Aug. 28 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading manufacturer and developer of intravascular ultrasound (IVUS), functional measurement (FM) and Optical Coherence Tomography (OCT) products designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the Thomas Weisel Partners 2008 Healthcare Conference on Thursday, September 4.
The presentation by Scott Huennekens, president and chief executive officer, will begin at 3:50 p.m., Eastern Daylight Time (12:50 p.m., Pacific Daylight Time).
The presentation will be available through the conference website at http://www.veracast.com/webcasts/twp/healthcare08/54213429.cfm or via the company's website at http://www.volcanocorp.com.
Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices
designed to facilitate endovascular procedures, enhance the diagnosis of
vascular and structural heart disease and guide optimal therapies. The
company's intravascular ultrasound (IVUS) product line includes ultrasound
consoles that can be integrated directly into virtually any modern cath
lab. Volcano IVUS offers unique features, including both single-use phased
array and rotational IVUS imaging catheters, and advanced functionality
options, such as VH(TM) tissue characterization and ChromaFlo(R). Volca
|SOURCE Volcano Corporation|
Copyright©2008 PR Newswire.
All rights reserved